Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding

Human Reproduction

Volumn 25, Issue 2, 2010, Pages 345-353

  Warner, P ^a   Guttinger, A ^b   Glasier, A F ^b,c   Lee, R J ^a   Nickerson, S ^c   Brenner, R M ^d   Critchley, H O D ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NHS LOTHIAN   (United Kingdom)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CDB 2914; Endometrium; LNG IUS; Unscheduled bleeding

Indexed keywords

LEVONORGESTREL; PLACEBO; PROGESTERONE RECEPTOR MODULATOR; ULIPRISNIL ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEVICE REMOVAL; DRUG EFFECT; DRUG EFFICACY; FEMALE; FLUID RETENTION; FOLLOW UP; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MASTALGIA; MENSTRUAL CYCLE; MOOD CHANGE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PAIN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN TOXICITY; SPOTTING; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; VAGINA BLEEDING; WEIGHT GAIN;

EID: 74549165389     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep377     Document Type: Article

References (24)

1. Abdel-Aleem H, d'Arcangues C, Vogelsong KK, Gülmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD003449. DOI: 10.1002/14651858.CD003449.pub3. (Pubitemid 351805402)
2. Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996;174:919-922.
3. Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG 2000;107:335-339.
4. Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003;67:87-91.
5. Barbosa I, Bakos O, Olsson SE, Odlind V, Johansson ED. Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 1990; 42:51-66.
6. Blithe DL, Nieman LK, Blye RP, Stratton P, Passaro M. Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. Steroids 2003;68:1013-1017.
7. Cheng L, Zhu H, Wang A, Ren F, Chen J, Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000;15:1969-1972.
8. Cox M, Tripp J, Blacksell S. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plann Reprod Health Care 2002;28:73-77. (Pubitemid 34595935)
9. d'Arcangues C, Odlind V, Fraser IS. Dysfunctional uterine bleeding induced by exogenous hormones. In: Alexander NJ, d'Arcangues C (eds). Steroid Hormones and Uterine Bleeding. Washington: AAAS Press, 1992, 81-105.
10. Fraser IS, Hickey M. Endometrial vascular changes and bleeding disturbances with long-acting progestins. Steroids 2000;65: 665-670.
11. Gemzell-Danielsson K, van Heusden AM, Killick SR, Croxatto HB, Bouchard P, Cameron S, Bygdeman M. Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen. Hum Reprod 2002;17:2588-2593.
12. Glasier AF, Wang H, Davie JE, Kelly RW, Critchley HO. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study. Fertil Steril 2002;77:366-372.
13. Guttinger A, Critchley HO. Endometrial effects of intrauterine levonorgestrel. Contraception 2007;75:S93-S98.
14. Guttmacher Institute. Facts on Induced Abortion Worldwide. 2008; http://www.guttmacher.org/pubs/fb-IAW.html.
15. Halpern V, Grimes DA, Lopez LM, Gallo MF. Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004317. DOI:10.1002/14651858. CD004317.pub2.
16. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002;65:129-132. (Pubitemid 34258502)
17. Jain JK, Nicosia AF, Nucatola DL, Lu JJ, Kuo J, Felix JC. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 2003;68:1115-1119.
18. Massai MR, Pavez M, Fuentealba B, Croxatto HB, d'Arcangues C. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users. Contraception 2004;70:47-54.
19. National Institute for Health and Clinical Excellence (NICE). Long-acting reversible contraception. 2005; http://guidance.nice.org.uk/CG30.
20. Peterson HB, Curtis KM. Clinical practice. Long-acting methods of contraception. N Engl J Med 2005;353:2169-2175.
21. Trussell J. Contraceptive Efficacy. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Stewart FH, Kowal D (eds). Contraceptive Technology: Nineteenth Revised Edition. New York NY: Ardent Media, 2007.
22. Weisberg E, Hickey M, Palmer D, O'Connor V, Salamonsen LA, Findlay JK, Fraser IS. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006;21:295-302.
23. World Health Organization Reproductive Health and Research (WHO). Quality Care in Family Planning, Medical Eligibility Criteria for Contraceptive Use. Geneva: WHO, 2008. http://www.who.int/reproductive-health/publications/mec/ index.htm.
24. Xiao BL, Zhou LY, Zhang XL, Jia MC, Luukkainen T, Allonen H. Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device. Contraception 1990;41:353-362.